USD 3.34 billion
Onychomycosis Market Size, Share, Growth Analysis, By Type(Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis and others), By Treatment(Oral, topical and others), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2278 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
62
|Figures:
75
Onychomycosis Market Insights
Onychomycosis Market size was valued at USD 3.5 Billion in 2023 and is poised to grow from USD 3.66 Billion in 2024 to USD 5.29 Billion by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).
The global onychomycosis market refers to the pharmaceutical and healthcare industry focused on the diagnosis, treatment, and management of fungal infections affecting the nails, commonly known as onychomycosis. Onychomycosis is a prevalent condition that can cause discoloration, thickening, and brittleness of the nails, leading to discomfort and potential complications. The market is driven by various factors, including increasing awareness about nail health, rising prevalence of onychomycosis due to factors like aging population, diabetes, and weakened immune systems, and advancements in diagnostic techniques and treatment options. The market encompasses a range of products such as topical and oral antifungal medications, nail lacquers, and medical devices for nail debridement and laser therapy. Key players in the market include pharmaceutical companies, medical device manufacturers, and healthcare providers, who are actively involved in research and development, product launches, strategic collaborations, and mergers and acquisitions to expand their market presence and meet the growing demand for effective onychomycosis treatments. Geographically, the market is spread across various regions, with North America, Europe, and Asia Pacific being the major contributors. The global market is anticipated to witness significant growth in the coming years as the demand for innovative and convenient treatment options continues to rise, driven by the increasing focus on nail health and overall well-being.
US Onychomycosis Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Distal Subungual Onychomycosis
Fastest Growth
Distal Subungual Onychomycosis
Growth Rate
4.7% CAGR
Global Onychomycosis Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Onychomycosis Market Segmental Analysis
Global Onychomycosis Market is segmented on the basis of type, treatment, and region. Based on type, the market can be segmented into Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis and others. Based on treatment, the market is segmented into Oral, topical and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Onychomycosis Market Analysis By Type
The dominant segment in the global onychomycosis market is distal subungual onychomycosis. This type of fungal infection affects the nail bed and the underside of the nail, typically starting at the tip and gradually spreading towards the cuticle. Distal subungual onychomycosis is the most common form of onychomycosis, accounting for a significant portion of diagnosed cases worldwide. It is often associated with dermatophyte fungi and can result in nail discoloration, thickening, and deformities.
On the other hand, the fastest-growing segment in the global onychomycosis market is proximal subungual onychomycosis. This type of fungal infection begins at the base of the nail near the cuticle and progresses towards the free edge. Proximal subungual onychomycosis is often caused by opportunistic fungi and is commonly observed in individuals with compromised immune systems or those who have experienced trauma to the nail. This segment is witnessing rapid growth due to the increasing incidence of immunocompromised conditions and the rising awareness and diagnosis of fungal nail infections in high-risk populations.
Onychomycosis Market Analysis By Treatment
The dominant segment in the global onychomycosis market based on treatment is the oral treatment category. Oral antifungal medications are considered the gold standard for treating moderate to severe cases of onychomycosis. These medications work systemically, targeting the underlying fungal infection throughout the body. They are often prescribed for a specific duration and require regular monitoring for potential side effects. Oral treatments offer convenience and effectiveness in combating onychomycosis, making them a preferred choice for many patients and healthcare providers.
On the other hand, the fastest-growing segment in the global onychomycosis market is the topical treatment category. Topical antifungal medications are applied directly to the affected nails and surrounding areas. They come in various forms such as creams, gels, lacquers, and solutions. Topical treatments are gaining popularity due to their ease of use, lower risk of systemic side effects, and the availability of over-the-counter options. Advances in formulation technology have also led to the development of more effective and cosmetically appealing topical treatments, driving their growth in the market.
Global Onychomycosis Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Onychomycosis Market Regional Insights
The dominant segment in the global onychomycosis market based on region is North America. North America has a significant market share in onychomycosis due to factors such as a high prevalence of fungal infections, well-established healthcare infrastructure, advanced diagnostic and treatment options, and a strong presence of key market players. The region is characterized by increased awareness about nail health and a proactive approach towards managing onychomycosis, driving the demand for effective treatment solutions.
On the other hand, the fastest-growing segment in the global onychomycosis market is Asia Pacific. Asia Pacific is witnessing rapid growth in onychomycosis market due to factors such as the increasing geriatric population, rising prevalence of diabetes and other risk factors associated with fungal infections, improving healthcare infrastructure, and growing awareness about nail health and fungal infections. Moreover, the availability of cost-effective treatment options and the expansion of pharmaceutical companies in the region contribute to the market's growth in Asia Pacific.
Global Onychomycosis Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Onychomycosis Market Dynamics
Onychomycosis Market Drivers
Increasing prevalence of risk factors
- One key driver of the global onychomycosis market is the increasing prevalence of risk factors such as diabetes, aging population, weakened immune systems, and nail trauma. These factors contribute to a higher susceptibility to fungal infections, leading to a growing patient pool requiring diagnosis and treatment for onychomycosis.
Onychomycosis Market Restraints
Potential side effects and limitations associated with current treatment options
- A key restraint in the market is the potential side effects and limitations associated with current treatment options. While oral antifungal medications are considered effective, they may pose risks of systemic side effects and require careful monitoring. Additionally, topical treatments may have limited efficacy in treating severe or deep-seated infections. These factors can hinder the overall market growth and pose challenges in providing safe and optimal treatment options for patients with onychomycosis.
Request Free Customization of this report to help us to meet your business objectives.
Onychomycosis Market Competitive Landscape
The competitive landscape of the global onychomycosis market is characterized by intense competition among various pharmaceutical and healthcare companies. Market players focus on research and development activities to innovate and introduce advanced diagnostic tools, treatment options, and therapeutic approaches for onychomycosis. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are common strategies employed by companies to strengthen their market presence, expand their product portfolios, and enhance their global reach. The market is driven by the need for safe, effective, and convenient treatments, leading to a dynamic and competitive environment where companies strive to differentiate themselves and capture a significant share of the onychomycosis market.
Onychomycosis Market Top Player’s Company Profiles
- Bausch Health Companies Inc. (Canada)
- GSK plc (UK)
- Abbott (US)
- Pfizer Inc. (US)
- Bayer AG (Germany)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Cipla Inc. (India)
- Merck & Co., Inc. (US)
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Sanofi (France)
- Johnson & Johnson (US)
- Eli Lilly and Company (US)
- Mylan N.V. (US)
- Galderma S.A. (Switzerland)
- Valeant Pharmaceuticals International, Inc. (Canada)
- Sandoz International GmbH (Germany)
- Lupin Limited (India)
- Dr. Reddy's Laboratories Ltd. (India)
- Aurobindo Pharma Limited (India)
Onychomycosis Market Recent Developments
- In July 2021, Almirall S.A. established a licensing and distribution agreement with Kaken Pharmaceutical for the development and commercialization of Efinaconazole, a topical formulation used for the treatment of onychomycosis.
- In April 2021, Alembic Pharmaceuticals Limited announced that its joint venture, Aleor Dermaceuticals Limited, had received tentative approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) of Efinaconazole Topical Solution. This approval allows for the treatment of onychomycosis in the toenail.
- In February 2021, Lupin Limited obtained approval from the US Food and Drug Administration (FDA) for its Tavaborole Topical Solution, which is used for the treatment of onychomycosis.
Onychomycosis Key Market Trends
- Growing focus on the development of innovative and convenient treatment options: One key market trend in the global onychomycosis market is the growing focus on the development of innovative and convenient treatment options. There is an increasing demand for therapies that offer improved efficacy, shorter treatment duration, and enhanced patient compliance. Market players are investing in research and development to introduce novel formulations, such as topical solutions and lacquers, as well as exploring advanced technologies like laser therapy for more effective and targeted treatment of onychomycosis. This trend reflects the industry's commitment to addressing patient needs and improving outcomes in the management of fungal nail infections.
Onychomycosis Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our Global Onychomycosis Market analysis, the global market encompasses the diagnosis, treatment, and management of fungal nail infections. Key drivers of the market include the rising prevalence of risk factors like diabetes and aging population, as well as increasing awareness about nail health. The dominant segment in terms of type is distal subungual onychomycosis, while oral treatment is the dominant segment in terms of treatment options. North America holds a significant market share, while Asia Pacific is the fastest-growing region. The market is highly competitive, with companies focusing on research and development, strategic collaborations, and mergers and acquisitions. The development of innovative and convenient treatment options is a notable market trend, driven by the demand for improved efficacy and patient compliance.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 3.34 billion |
| Market size value in 2031 | USD 5.05 billion |
| Growth Rate | 4.7% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Onychomycosis Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Onychomycosis Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Onychomycosis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Onychomycosis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Onychomycosis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Onychomycosis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
